Why do none of Chinese pharmaceutical companies enter the top 50 in the world?
Release time: 2010-10-26 & nbsp & nbsp & nbsp Source:
October 25，China Foreign Investment Enterprise Association Drug Development and Development Industry Committee (RDPAC) released the report of the "Report on the Quality System of Pharmaceutical Enterprises"。In order to allow Chinese pharmaceutical companies to better cooperate with the new medical reform，Continuously actively improve the quality of medicine，RDPAC and American Pharmaceutical Research and Manufacturers Association (PHRMA) jointly commissioned Ernst & Ern & Ern & Ern & The quality system of Chinese pharmaceutical companies。Research by 13 leading pharmaceutical companies and a large number of industry interests，Summarize the nine key elements of the quality system of pharmaceutical production enterprises。"These nine major elements are established for enterprises、Maintenance and execution quality system is important，represents the advanced experience of these pharmaceutical stake online sports bettingStake Sports Bettingcompanies; at the same time, this information will help regulatory agencies and the entire industry in depth the practical activities of the quality management system，It laid the foundation for science for further assistance to the government to formulate relevant incentive measures。"Mr. Liu Zhenxian, president of RDPAC said。
The perfect drug quality system should cover the entire life cycle of the product
"Process decision results，Therefore, this study is not only concerned about the quality of the narrow sense，Instead, examine the effective measures of enterprises to ensure product quality from the entire life cycle of the medicine，is the difference in studying the quality management system of the enterprise。Research Discovery，Also a pharmaceutical company with GMP certification，Due to the different quality management system，Drug quality may have a large difference。We cannot test each dose of medicine，Sample inspection can only have a approximate judgment on the quality of these drugs，Therefore, only the test of the finished pharmaceutical ingredients cannot completely ensure the continuous stability of the quality of the drug，A complete quality system is essential; second，Drug quality guarantee work shall run through the entire life cycle from production to drug listing，Four important links in the value chain of the pharmaceutical value chain: production、Clinical verification、Drug Alert、Medical Information and Medical Affairs。Enterprise as a strict executive as a drug quality standard，Active efforts should be made to continuously improve the quality of medicines。Drug Alert、A series of measures after the pharmaceutical information services are exported by companies，It is indispensable stake online sports bettingstake sports betting appto continue to improve the quality of medicines。Finally, we also understand that pharmaceutical companies need to invest a lot of capital investment and professional knowledge，Some large pharmaceutical companies are as many as thousands of people in the world in drug safety related。"The main researcher of this study、Dr. Che Yan of An Yong said。
None of the 5,000 pharmaceutical companies have entered the top 50 of the world pharmaceutical
Made in China with its advantages of quality and low price and low -selling global，Created a lot of world -class enterprises，Ruhua、Lenovo、Chinese ships, etc.。But the Chinese pharmaceutical industry is large but not strong -5,000 pharmaceutical companies have entered the top 50 in the World Pharmaceuticals，Even from the perspective of generic drugs，Chinese business distance Teva、Mimic Drug Giants such as Yam Dexes also have a lot of gaps。Entering the international market is the ideal of many Chinese pharmaceutical companies，Compared with pharmaceutical companies in other countries，Chinese drug prices are already very competitive，The price of many medicines is less than one penny and a piece，But because the quality management system has not been in line with international standards，It makes it difficult for many Chinese companies to enter WHO and various charitable funds such as Various institutions.。By 2012, there will be $ 139 billion of drugs to lose patent protection，This will be a good opportunity for Chinese pharmaceutical companies to go to the international market for "first imitation" and brand imitation，Only Chinese enterprises have the opportunity to walk from China to the world from China to the world to share this huge cake，Complete the transformation from "big" to "strong"。
Policy incentives and guidance are the key to the successful upgrade My stake betting appof the Chinese pharmaceutical industry
Stake Sports BettingRDPAC Health and Economic Affairs Director Chen Yi said: "Development of the development experience of mature international pharmaceutical markets，Government's incentive policy is important to guide the healthy development of the pharmaceutical industry。For example: Japanese government to encourage enterprises to create new drugs，Innovation in the pricing system of the new drug、Effective、Multiple indicators such as suitable marketing/marketing and pediatric drugs，And the total bonus is not set up。Since 2002，The Japanese government's increase in the price increase from 40%to 70%-120%in 2008，The average R & D investment of the top ten pharmaceutical companies in Japan during the same period also increased from 13.8%of sales to 20.9%，The guidance of the policy is very obvious。Innovation and quality are like DNA in the cell Double spiral，But if the company's investment in improving quality and innovation cannot be rewarded，Then the motivation of increasing investment in the enterprise will no longer exist。”
Drugs as special products，Can't be measured by price，Quality is the key。The current pharmaceutical policy such as the price management framework and bidding of the drug has fully considered the most basic requirements for most people available for medicine，but not fully considered the source of research and development of drug quality to improve the source of drug quality、Paratory reactions monitoring and medical information service costs，Not only is it not conducive to the long -term development of Chinese pharmaceutical companies，At the same time, it is also easy to produce hidden dangers of quality and drug safety。Mr. Liu Zhenxian pointed out: high quality and My stake betting apphigh price、Encouraging R & stake betting appD policy to motivates to promote the spontaneous investment of the enterprise，Improving drug research and development capabilities and quality，To ensure the safety of the use of medications in the general public; it also helps to improve the concentration of the industry，Help more companies participate in international competition，At the same time, this is also the key to China's development from a large pharmaceutical country to a pharmaceutical power，Eventually benefit the people。
The perfect drug quality system should cover the entire life cycle of the product
"Process decision results，Therefore, this study is not only concerned about the quality of the narrow sense，Instead, examine the effective measures of enterprises to ensure product quality from the entire life cycle of the medicine，is the difference in studying the quality management system of the enterprise。Research Discovery，Also a pharmaceutical company with GMP certification，Due to the different quality management system，Drug quality may have a large difference。We cannot test each dose of medicine，Sample inspection can only have a approximate judgment on the quality of these drugs，Therefore, only the test of the finished pharmaceutical ingredients cannot completely ensure the continuous stability of the quality of the drug，A complete quality system is essential; second，Drug quality guarantee work shall run through the entire life cycle from production to drug listing，Four important links in the value chain of the pharmaceutical value chain: production、Clinical verification、Drug Alert、Medical Information and Medical Affairs。Enterprise as a strict executive as a drug quality standard，Active efforts should be made to continuously improve the quality of medicines。Drug Alert、A series of measures after the pharmaceutical information services are exported by companies，It is indispensable stake online sports bettingstake sports betting appto continue to improve the quality of medicines。Finally, we also understand that pharmaceutical companies need to invest a lot of capital investment and professional knowledge，Some large pharmaceutical companies are as many as thousands of people in the world in drug safety related。"The main researcher of this study、Dr. Che Yan of An Yong said。
None of the 5,000 pharmaceutical companies have entered the top 50 of the world pharmaceutical
Made in China with its advantages of quality and low price and low -selling global，Created a lot of world -class enterprises，Ruhua、Lenovo、Chinese ships, etc.。But the Chinese pharmaceutical industry is large but not strong -5,000 pharmaceutical companies have entered the top 50 in the World Pharmaceuticals，Even from the perspective of generic drugs，Chinese business distance Teva、Mimic Drug Giants such as Yam Dexes also have a lot of gaps。Entering the international market is the ideal of many Chinese pharmaceutical companies，Compared with pharmaceutical companies in other countries，Chinese drug prices are already very competitive，The price of many medicines is less than one penny and a piece，But because the quality management system has not been in line with international standards，It makes it difficult for many Chinese companies to enter WHO and various charitable funds such as Various institutions.。By 2012, there will be $ 139 billion of drugs to lose patent protection，This will be a good opportunity for Chinese pharmaceutical companies to go to the international market for "first imitation" and brand imitation，Only Chinese enterprises have the opportunity to walk from China to the world from China to the world to share this huge cake，Complete the transformation from "big" to "strong"。
Policy incentives and guidance are the key to the successful upgrade My stake betting appof the Chinese pharmaceutical industry
Stake Sports BettingRDPAC Health and Economic Affairs Director Chen Yi said: "Development of the development experience of mature international pharmaceutical markets，Government's incentive policy is important to guide the healthy development of the pharmaceutical industry。For example: Japanese government to encourage enterprises to create new drugs，Innovation in the pricing system of the new drug、Effective、Multiple indicators such as suitable marketing/marketing and pediatric drugs，And the total bonus is not set up。Since 2002，The Japanese government's increase in the price increase from 40%to 70%-120%in 2008，The average R & D investment of the top ten pharmaceutical companies in Japan during the same period also increased from 13.8%of sales to 20.9%，The guidance of the policy is very obvious。Innovation and quality are like DNA in the cell Double spiral，But if the company's investment in improving quality and innovation cannot be rewarded，Then the motivation of increasing investment in the enterprise will no longer exist。”
Drugs as special products，Can't be measured by price，Quality is the key。The current pharmaceutical policy such as the price management framework and bidding of the drug has fully considered the most basic requirements for most people available for medicine，but not fully considered the source of research and development of drug quality to improve the source of drug quality、Paratory reactions monitoring and medical information service costs，Not only is it not conducive to the long -term development of Chinese pharmaceutical companies，At the same time, it is also easy to produce hidden dangers of quality and drug safety。Mr. Liu Zhenxian pointed out: high quality and My stake betting apphigh price、Encouraging R & stake betting appD policy to motivates to promote the spontaneous investment of the enterprise，Improving drug research and development capabilities and quality，To ensure the safety of the use of medications in the general public; it also helps to improve the concentration of the industry，Help more companies participate in international competition，At the same time, this is also the key to China's development from a large pharmaceutical country to a pharmaceutical power，Eventually benefit the people。
